Elil Lilly

Elil Lilly, Retevmo, Thyroid Cancer, Roche, RET-driven cancers, Gavreto

Eli Lilly Sets Example for Roche with Positive Retevmo Results in Thyroid Cancer, Highlighting Feasibility of Trial

Anika Sharma

Just a few weeks ago, Roche had expressed doubts about the feasibility of a Phase 3 study involving its RET ...